SCTXのROE（自己資本利益率）は？

Scribe Therapeutics Inc. Common StockのROEは13.09%です。

SCTXの配当利回りは？

Scribe Therapeutics Inc. Common Stockの配当利回りは0.00%です。

SCTXの品質スコア（Quality Score）は？

当社のAIはSCTXの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

SCTXは今が買い時ですか？

当社AIのタイミングスコアは100点中1点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

SCTXはどのセクターに属しますか？

Scribe Therapeutics Inc. Common StockはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

SCTX (NASDAQ) 株価分析 | SCRIBE THERAPEUTICS INC. COMMON STOCK

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2026-03-31)

SCTX AI Analysis Summary

Our AI summary for SCTX: Scribe Therapeutics Inc. Common Stock (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of 13.09%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 1/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

SCTX

Scribe Therapeutics Inc. Common Stock

US:NASDAQ STOCK Healthcare >> Biotechnology News 98

USD 22.06

1.23 (5.88%) Day Change

Watchlist Portfolio Compare Chart

-1.41

D/E

13.1%

ROE

-31.9%

ROA

0.00%

Div Yield

SCRIBE THERAPEUTICS INC. COMMON STOCK
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 22.06 Price 1.23 (5.88%) Day Change	NEWS SCORE: 98

SCTX, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そしてテクニカルスコアは ...(Sign In to See)...

No price data to display chart for the last 3-months of this stock

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROAが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
ROAの伸びが低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析

39%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	98
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	22.06
PBV / Sector	-2.12 / 44,022.72
Earning Per Share	-1.36

PE / Sector	N/A / 19.17
PEG or PE/Growth / Sector	N/A / 1.24
Average 1M Daily Value	6.65 M
Average 1W Daily Value	3.26 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

54%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-107.30 / 98.24
NPM Average (%) / Sector	-108.08 / -1,697.63
NPM Change Average (%) / Sector	38.12 / 5,097.97 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-31.85 / 185,260.96
ROA Average (%) / Sector	-32.36 / 36,684.70
ROA Change Average (%) / Sector	-5.54 / 422,221.66
ROE (%) / Sector	13.09 / 243,762.23
ROE Average (%) / Sector	22.09 / 48,758.47 GOOD
ROE Change Average (%) / Sector	-36.95 / 424,968.10
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.49

登録情報

Analyze Date	2026-08-05 08:00:49
Symbol	SCTX
Name	SCRIBE THERAPEUTICS INC. COMMON STOCK
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	16.18 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	337.15 / 9,586.08

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1150 Marina Village Pkwy, Alameda, CA, United States, 94501

Phone: 510 626 8587

Website: https://www.scribetx.com

Employees: 89

Sector: Healthcare >> Biotechnology

Description: Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on cardiometabolic conditions in the United States. The company offers STX-1150 designed to be a single-course in vivo epigenetic silencing treatment targeting the PCSK9 gene; STX-1200 is CRISPR-based gene editing program that aims to offer a permanent solution for patients with elevated Lp(a); and STX-1400 is designed to target and remove the transcriptional start site of the APOC3 gene and strongly reduce mRNA expression. It uses CRISPR-based platforms, such as ELXR, designed for precise, durable epigenetic silencing of genes without changing the underlying DNA sequence; and XE, designed to support specific and efficient gene editing. The company was incorporated in 2017 and is headquartered in Alameda, California.